Sign in

CIK 0001781174 · <br>Emerging growth company

Acrivon Therapeutics, Inc.

Sign in to watch
Ticker
ACRV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
825125532
Phone
617-207-8979
Business address
480 ARSENAL WAY, SUITE 100, WATERTOWN, MA, 02472
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$38,534
in 8 filings

Net −$38,534. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Blume-Jensen Peter −$34K President and CEO sold <1% of stake
  2. Miller Mary −$2K Chief Legal Officer sold 1% of stake
  3. Devroe Eric −$1K Chief Operating Officer sold <1% of stake
  4. Gamelin Erick −$804 Chief Development Officer sold <1% of stake
  5. Peterson Katharine −$203 Chief Accounting Officer sold <1% of stake

Reading 84 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-08-18 Devroe Eric Chief Operating Officer Sale −604 $2.01 $1K 146,349
2026-05-18 Devroe Eric Chief Operating Officer Grant or award +72,981 146,953
2026-05-14 Devroe Eric Chief Operating Officer Shares withheld for taxes −613 $1.92 $1K 73,972
2026-03-01 Devroe Eric Chief Operating Officer Grant or award · Stock Option (Right to Buy) +186,728 186,728
2026-02-14 Devroe Eric Chief Operating Officer Shares withheld for taxes −723 $1.63 $1K 74,585
2026-01-13 Devroe Eric Chief Operating Officer Purchase +10,000 $1.72 $17K 75,308
2025-11-14 Devroe Eric Chief Operating Officer Shares withheld for taxes −613 $2.24 $1K 65,308
2025-08-14 Devroe Eric Chief Operating Officer Shares withheld for taxes −613 $1.39 $852 65,921
2025-05-14 Devroe Eric Chief Operating Officer Shares withheld for taxes −613 $1.14 $699 66,534
2025-03-01 Devroe Eric Chief Operating Officer Grant or award · Stock Option (Right to Buy) +140,540 140,540

Page 1 of 1 · 10 trades